BIMC
ABBV icon

Benson Investment Management Company’s AbbVie ABBV Stock Holding History

Benson Investment Management Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26,496
Closed -$4.71M – 49
2024
Q4 		$4.71M Buy
+26,496
New +$4.87M 1.96% 31

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Benson Investment Management Company's ABBV Position: Q1 2025 in Review

Benson Investment Management Company sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 26,496 shares — an estimated $4.71M sold.

Benson Investment Management Company first reported a position in ABBV in Q4 2024 and held it in 1 quarter. The position peaked at $4.71M in Q4 2024. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Benson Investment Management Company reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Benson Investment Management Company sold 26,496 AbbVie shares in Q1 2025, an estimated $4.71M.
  • Benson Investment Management Company first reported a position in AbbVie in Q4 2024 and held it in 1 quarter.
  • Benson Investment Management Company's AbbVie position peaked at $4.71M in Q4 2024.
  • 3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Benson Investment Management Company's 13F filing for Q1 2025, filed 10 Apr 2025.